ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

PMD Psychemedics Corporation

2,55
-0,0863 (-3,27%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Psychemedics Corporation PMD NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,0863 -3,27% 2,55 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
2,64 2,53 2,64 2,55 2,6363
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
28.3.202413:20GLOBEPsychemedics Corporation Reports 2023 Financial Results
21.3.202414:00GLOBEPsychemedics Recognized as a Top 10 Employee Health Testing..
13.2.202415:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02.2.202422:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26.1.202422:10EDGAR2Form 8-K - Current report
24.1.202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.1.202417:27GLOBEPsychemedics Corporation Announces Relocation of..
19.12.202322:59EDGAR2Form 3 - Initial statement of beneficial ownership of..
14.12.202318:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
27.11.202317:31EDGAR2Form 8-K - Current report
27.11.202315:00GLOBEPsychemedics Corporation Appoints Daniella Mehalik as VP -..
13.11.202323:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.11.202323:00GLOBEPsychemedics Corporation Reports Third Quarter 2023..
09.11.202323:00EDGAR2Form 8-K - Current report
08.11.202323:00EDGAR2Form 8-K - Current report
27.10.202317:00GLOBEUnveiling the Future of Drug Testing: Psychemedics..
26.9.202300:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.9.202319:00EDGAR2Form 8-K - Current report
21.9.202323:00GLOBEPsychemedics Corporation Appoints Shannon Shoemaker as Chief..
31.8.202323:20EDGAR2Form 8-K - Current report
22.8.202323:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.8.202323:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
21.8.202323:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.8.202323:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.8.202323:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.8.202323:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.8.202323:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.8.202323:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.8.202323:01EDGAR2Form 8-K - Current report
18.8.202320:00GLOBEPsychemedics Corporation Reports Inducement Grants Under..
17.8.202323:30EDGAR2Form 144 - Report of proposed sale of securities
14.8.202323:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11.8.202323:10GLOBEPsychemedics Corporation Reports Second Quarter 2023..
11.8.202323:10EDGAR2Form 8-K - Current report
21.7.202323:00EDGAR2Form 8-K - Current report
21.7.202322:00EDGAR2Form DEF 14A - Other definitive proxy statements
14.7.202315:15EDGAR2Form 8-K - Current report
12.7.202323:15GLOBEPsychemedics Corporation Announces CEO Succession Plan
09.5.202323:30GLOBEPsychemedics Corporation Reports First Quarter 2023..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock